$13.40
▲ +$0.38
(+2.92%)
Vol 1.2M
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.5B
ROE
-76.1%
Margin
-486.0%
D/E
0.00
Beta
1.73
52W
$4–$19
Wall Street Consensus
18 analysts · Apr 20266
Strong Buy
11
Buy
1
Hold
0
Sell
0
Strong Sell
94.4%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.76 | $-0.81 | $-0.05 |
| Sep 2025 | $-0.80 | $-0.85 | $-0.05 |
| Jun 2025 | $-0.81 | $-0.85 | $-0.04 |
| Mar 2025 | $-0.67 | $-0.65 | +$0.02 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $11.6M | $24.5M | $5.3M | $966K | $620K |
| Net Income | — | -$41.4M | -$45.2M | -$59.4M | -$59.7M | -$67.6M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -63.8% | -63.8% | -63.8% | -63.8% | -76.1% | -76.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -1114.3% | -337.9% | -337.9% | -337.9% | -485.9% | -485.9% |
| Gross Margin | 96.9% | 95.1% | 95.1% | 95.1% | 94.1% | 94.1% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 8.00 | 8.00 | 8.00 | 8.00 | 7.18 | 7.18 |
Key Ratios
ROA (TTM)
-61.7%
P/S (TTM)
35.72
P/B
1.5
EPS (TTM)
$-2.99
CF/Share
$-2.64
Rev Growth 3Y
+5.4%
52W High
$19.11
52W Low
$3.91
$3.91
52-Week Range
$19.11
Financial Health
Free Cash Flow
-$66.0M
Net Debt
-$81.0M
Cash
$101.8M
Total Debt
$20.8M
As of Dec 31, 2025
How does EYPT compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
EYPT valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
35.7
▲
622%
above
peers
(5.0)
vs Peers
vs Industry
Pricier
P/B ratio
1.5
▼
29%
below
peers
(2.1)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
EYPT profitability vs Pharmaceuticals peers
ROE
-76.1%
▼
40%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
-486.0%
▼
926%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
94.1%
▲
38%
above
peers
(68.3%)
vs Peers
vs Industry
Below avg
ROA
-61.7%
▼
65%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
EYPT financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
7.2
▲
114%
above
peers
(3.4)
vs Peers
vs Industry
Below avg
Beta
1.7
▲
84%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
EYPT fundamentals radar
EYPT
Peer median
Industry
EYPT profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
EYPT vs peers: key metrics
Latest News
No related news yet